Treatment with anti-TIMP1 reduced mammary collagen deposition by 63% in UTI-bearing PLI mice, relative to IgG controls, as similarly observed in nulliparous UTI-bearing mice (Fig. 5K, L). The gene discussed is TIMP1; the disease is bacterial urinary tract infection.